05:14 PM EDT, 04/24/2024 (MT Newswires) -- Chemed ( CHE ) reported Q1 adjusted earnings late Wednesday of $5.20 per diluted share, up from $4.28 a year earlier.

Four analysts surveyed by Capital IQ expected $5.48.

Revenue for the quarter ended March 31 was $589.2 million, up from $560.2 million a year earlier.

Four analysts surveyed by Capital IQ expected $591.1 million.

The company reiterated its full-year 2024 adjusted EPS guidance of $23.30 to $23.70. Three analysts surveyed by Capital IQ expect $23.52.

The company's shares were down nearly 2% in after-hours activity.

Price: 607.75, Change: -10.20, Percent Change: -1.65